Clinical Study

A Phase 1 Study Of Stereotactic Body Radiotherapy (Sbrt) For The Treatment Of Multiple Metastases

Posted Date: Mar 31, 2017

  • Investigator: Kevin Redmond
  • Co-Investigator: Kevin Redmond
  • Specialties: Breast Cancer, Hematology/Oncology, Prostate Cancer, Oncology, Cancer, Lung Cancer, Radiation Oncology
  • Type of Study: Drug

This research is being done to study the safety of giving high doses of radiation to cancer that has spread to other parts of the body. This type of radiation is called stereotactic body radiotherapy [SBRT]). SBRT delivers high doses of radiation to an


To Be Eligible For This Study, Patients Must Have Breast, Lung Or Prostate Cancer That Has Spread To Other Parts Of The Body.


Phase I, Cancer, Nrg-Br001, Radiation, Solid Tumor

For More Information:

Uc Cancer Institute

  • Search Clinical Studies

  • Research in the News

    Ride Cincinnati Gives $200,000 in Grants for Breast Cancer Research

    Marlene Harris-Ride Cincinnati has continued its support of UC Cancer Institutescientists with the annual award of five grants to continue promising breastcancer research.